Direct Oral Anticoagulants in Patients on Chronic Dialysis and Concomitant Atrial Fibrillation: A Common Clinical Impasse
The most frequent arrhythmia treated is atrial fibrillation (AF), which necessitates the use of oral anticoagulants (OACs) to reduce the risk of thromboembolism and stroke. Patients with chronic kidney disease are more likely to develop AF, with a 10% frequency among those on chronic dialysis. Warfa...
Main Authors: | Nikolaos Ktenopoulos, Marios Sagris, Panagiotis Theofilis, Sophia Lionaki, Loukianos S. Rallidis |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2022-07-01
|
Series: | Frontiers in Bioscience-Scholar |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/FBS/14/3/10.31083/j.fbs1403021 |
Similar Items
-
Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients
by: Alessandra M. Campos-Staffico, et al.
Published: (2022-11-01) -
Prescribing and Safety of Direct-Acting Oral Anticoagulants Compared to Warfarin in Patients with Atrial Fibrillation on Chronic Hemodialysis
by: Estella Davis, et al.
Published: (2020-03-01) -
A Systematic Review of the Efficacy and Safety of Direct Oral Anticoagulants in Atrial Fibrillation Patients with Diabetes Using a Risk Index
by: Domenico Acanfora, et al.
Published: (2021-06-01) -
Patients’ and clinicians’ perceptions of oral anticoagulants in atrial fibrillation: a systematic narrative review and meta-analysis
by: Yeyenta Mina Osasu, et al.
Published: (2021-12-01) -
Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort study
by: Wenlin Xu, et al.
Published: (2023-11-01)